ES552502A0 - Un procedimiento para la preparacion de nuevos derivados de tiazolidina. - Google Patents
Un procedimiento para la preparacion de nuevos derivados de tiazolidina.Info
- Publication number
- ES552502A0 ES552502A0 ES552502A ES552502A ES552502A0 ES 552502 A0 ES552502 A0 ES 552502A0 ES 552502 A ES552502 A ES 552502A ES 552502 A ES552502 A ES 552502A ES 552502 A0 ES552502 A0 ES 552502A0
- Authority
- ES
- Spain
- Prior art keywords
- procedure
- preparation
- thiazolidine derivatives
- new thiazolidine
- new
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
- C07D311/24—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
- C07D311/70—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with two hydrocarbon radicals attached in position 2 and elements other than carbon and hydrogen in position 6
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
- C07D311/70—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with two hydrocarbon radicals attached in position 2 and elements other than carbon and hydrogen in position 6
- C07D311/72—3,4-Dihydro derivatives having in position 2 at least one methyl radical and in position 6 one oxygen atom, e.g. tocopherols
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/10—Spiro-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP3532485 | 1985-02-26 | ||
| JP3532585 | 1985-02-26 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ES8802046A1 ES8802046A1 (es) | 1988-03-16 |
| ES552502A0 true ES552502A0 (es) | 1988-03-16 |
Family
ID=26374301
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES552502A Expired ES8802046A1 (es) | 1985-02-26 | 1986-02-26 | Un procedimiento para la preparacion de nuevos derivados de tiazolidina. |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US5104888A (es) |
| EP (1) | EP0207581B1 (es) |
| KR (1) | KR930003335B1 (es) |
| AU (1) | AU588857B2 (es) |
| CA (1) | CA1256106A (es) |
| DE (1) | DE3674089D1 (es) |
| DK (1) | DK173350B1 (es) |
| ES (1) | ES8802046A1 (es) |
| FI (1) | FI82693C (es) |
| IE (1) | IE58853B1 (es) |
Families Citing this family (58)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4873255A (en) * | 1987-02-04 | 1989-10-10 | Sankyo Company Limited | Thiazolidinone derivatives, their preparation and their use |
| US5015661A (en) * | 1988-08-09 | 1991-05-14 | Hoffmann-La Roche Inc. | Chromanes and their pharmaceutical compositions and methods |
| GB8919417D0 (en) | 1989-08-25 | 1989-10-11 | Beecham Group Plc | Novel compounds |
| JP2826379B2 (ja) * | 1990-01-22 | 1998-11-18 | 三共株式会社 | チアゾリジン誘導体を有効成分とする肥満性高血圧症治療剤 |
| GB9023584D0 (en) * | 1990-10-30 | 1990-12-12 | Beecham Group Plc | Novel compounds |
| FR2680512B1 (fr) * | 1991-08-20 | 1995-01-20 | Adir | Nouveaux derives de 2,4-thiazolidinedione, leur procede de preparation et les compositions pharmaceutiques qui les contiennent. |
| GB9124513D0 (en) * | 1991-11-19 | 1992-01-08 | Smithkline Beecham Plc | Novel process |
| CA2082003A1 (en) * | 1991-11-20 | 1993-05-21 | David Laffan | Process for the preparation of substituted pentaalkylchromenes |
| CA2089013A1 (en) * | 1992-02-21 | 1993-08-22 | Josef Heveling | Process for the preparation of 6-hydroxy-2, 5, 7, 8- tetraalkyl-2-(4-aminophenoxymethyl) chromans |
| CA2089012A1 (en) * | 1992-02-21 | 1993-08-22 | Josef Heveling | Process for the preparation of 6-hydroxy-2,5,7,8-tetra- alkyl-2-(4-aminophenoxymethyl) chromans |
| FR2696743B1 (fr) * | 1992-10-12 | 1994-12-23 | Adir | Nouveaux composés de thiazolidine dione, leur procédé de préparation et les compositions pharmaceutiques les contenant. |
| US5594016A (en) * | 1992-12-28 | 1997-01-14 | Mitsubishi Chemical Corporation | Naphthalene derivatives |
| JP2845743B2 (ja) * | 1992-12-28 | 1999-01-13 | 三菱化学株式会社 | 新規なナフタレン誘導体 |
| AU6114794A (en) * | 1993-02-24 | 1994-09-14 | Sankyo Company Limited | Arteriosclerosis remedy |
| USRE39384E1 (en) | 1993-09-01 | 2006-11-07 | Smithkline Beecham P.L.C. | Substituted thiazolidinedione derivatives |
| CA2146701A1 (en) * | 1994-04-11 | 1995-10-12 | Takashi Fujita | Heterocyclic compounds having anti-diabetic activity, their preparation and their use |
| JP3871354B2 (ja) * | 1994-07-29 | 2007-01-24 | 株式会社フジモト・コーポレーション | 新規な２−（ｎ−シアノイミノ）チアゾリジン−４−オン誘導体 |
| CA2159938A1 (en) * | 1994-10-07 | 1996-04-08 | Hiroaki Yanagisawa | Oxime derivatives, their preparation and their therapeutic use |
| CZ293016B6 (cs) * | 1995-06-01 | 2004-01-14 | Sankyo Company Limited | Benzimidazolové deriváty a farmaceutické prostředky s jejich obsahem |
| US5889032A (en) * | 1996-05-06 | 1999-03-30 | Dr. Reddy's Research Foundation | Heterocyclic compounds having antidiabetic, hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them |
| US5801173A (en) * | 1996-05-06 | 1998-09-01 | Dr. Reddy's Research Foundation | Heterocyclic compounds having antidiabetic, hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them |
| US5919782A (en) * | 1996-05-06 | 1999-07-06 | Dr. Reddy's Research Foundation | Heterocyclic compounds having antidiabetic, hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them |
| ZA973850B (en) * | 1996-05-06 | 1997-12-02 | Reddy Research Foundation | Novel antidiabetic compounds having hypolipidaemic, anti-hypertensive properties, process for their preparation and pharmaceutical compositions containing them. |
| DE19619819A1 (de) * | 1996-05-16 | 1997-11-20 | Boehringer Mannheim Gmbh | Neue Thiazolidindione, Verfahren zu ihrer Herstellung und diese enthaltenden Arzneimittel |
| AU744518B2 (en) | 1996-07-01 | 2002-02-28 | Dr. Reddy's Laboratories Limited | Novel heterocyclic compounds process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases |
| US5885997A (en) * | 1996-07-01 | 1999-03-23 | Dr. Reddy's Research Foundation | Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases |
| USRE39266E1 (en) * | 1996-07-01 | 2006-09-05 | Dr. Reddy's Laboratories, Limited | Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases |
| US6114526A (en) | 1996-07-01 | 2000-09-05 | Dr. Reddy's Research Foundation | Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases |
| US6372750B2 (en) | 1996-07-01 | 2002-04-16 | Dr. Reddy's Research Foundation | Heterocyclic compounds, process for their preparation and pharmaceutical compounds containing them and their use in the treatment of diabetes and related diseases |
| FR2760748A1 (fr) * | 1997-03-14 | 1998-09-18 | Rhodia Chimie Sa | Procede de preparation de 2h-1-benzopyranes |
| AP1600A (en) | 1997-06-18 | 2006-04-28 | Smithkline Beecham Plc | Combination of a thiazolidinedione and a sulphonylurea for treating diabetes |
| FR2766820B1 (fr) * | 1997-07-31 | 1999-10-22 | Rhodia Chimie Sa | Procede de preparation de 2h-1-benzopyranes et intermediaires de synthese utiles dans la mise en oeuvre du procede |
| BR9812770A (pt) | 1997-10-27 | 2000-12-12 | Reddy Research Foundation | Compostos bicìclicos, processo para seu preparo e composições farmacêuticas contendo os mesmos |
| US6265401B1 (en) | 1997-10-27 | 2001-07-24 | Reddy-Cheminor, Inc. | Bicyclic compounds and their use in medicine, process for their preparation and pharmaceutical compositions containing them |
| US6440961B1 (en) | 1997-10-27 | 2002-08-27 | Dr. Reddy's Research Foundation | Tricyclic compounds and their use in medicine: process for their preparation and pharmaceutical compositions containing them |
| US6444816B1 (en) | 1997-10-27 | 2002-09-03 | Dr. Reddy's Research Foundation | Fused 7-oxo-pyrimidinyl compounds, preparation, composition and use thereof |
| US6369067B1 (en) | 1997-10-27 | 2002-04-09 | Dr. Reddy's Research Foundation | Monocyclic compounds and their use in medicine: process for their preparation and pharmaceutical compositions containing them |
| HUP0100072A3 (en) | 1997-10-27 | 2002-11-28 | Reddys Lab Ltd Dr | Phenoxazine, phenthiazine derivatives, their use in medicine; process for their preparation and pharmaceutical compositions containing them |
| EP1124807A1 (en) * | 1997-10-27 | 2001-08-22 | Dr. Reddy's Research Foundation | Novel heterocyclic compounds and their use in medicine, process for their preparation and pharmaceutical compositions containing them |
| NZ504106A (en) * | 1998-05-27 | 2003-02-28 | Dr | Fused Oxazine, Thiazine and pipyridine compounds, process for their preparation and pharmaceutical compositions containing them |
| BR9915285A (pt) | 1998-11-12 | 2001-08-07 | Smithkline Beecham Plc | Composição farmacêutica para liberação modificada de um sensitivador de insulina e um outro agente antidiabético |
| AR023699A1 (es) | 1998-11-12 | 2002-09-04 | Smithkline Beecham Corp | Una composicion farmaceutica que comprende un estabilizador de insulina y un procedimiento para preparar una composicion farmaceutica |
| SK15092001A3 (sk) | 1999-04-28 | 2002-05-09 | Dr. Reddy's Research Foundation | Substituované bicyklické heterocyklické zlúčeniny, spôsob ich prípravy a ich použitie ako antiobezitných a hypocholesterolemických činidiel |
| AU6016200A (en) * | 1999-07-16 | 2001-02-05 | Sankyo Company Limited | Coumarone analogues |
| GB0014969D0 (en) | 2000-06-19 | 2000-08-09 | Smithkline Beecham Plc | Novel method of treatment |
| US8216609B2 (en) * | 2002-08-05 | 2012-07-10 | Torrent Pharmaceuticals Limited | Modified release composition of highly soluble drugs |
| US8268352B2 (en) * | 2002-08-05 | 2012-09-18 | Torrent Pharmaceuticals Limited | Modified release composition for highly soluble drugs |
| US20080207711A1 (en) * | 2007-02-28 | 2008-08-28 | Rong Li | Method for treating an ID2-related disorder |
| US8173621B2 (en) | 2008-06-11 | 2012-05-08 | Gilead Pharmasset Llc | Nucleoside cyclicphosphates |
| EP3222628A1 (en) * | 2008-12-23 | 2017-09-27 | Gilead Pharmasset LLC | Nucleoside phosphoramidates |
| US8551973B2 (en) * | 2008-12-23 | 2013-10-08 | Gilead Pharmasset Llc | Nucleoside analogs |
| US8716263B2 (en) | 2008-12-23 | 2014-05-06 | Gilead Pharmasset Llc | Synthesis of purine nucleosides |
| WO2010151711A1 (en) | 2009-06-25 | 2010-12-29 | Alkermes, Inc. | Prodrugs of nh-acidic compounds |
| JP2013520162A (ja) | 2010-01-22 | 2013-06-06 | デイナ ファーバー キャンサー インスティチュート，インコーポレイテッド | 代謝障害の同定、査定、予防および治療のための組成物、キットおよび方法 |
| PT3290428T (pt) | 2010-03-31 | 2021-12-27 | Gilead Pharmasset Llc | Comprimido compreendendo 2-(((s)-(((2r,3r,4r,5r)-5-(2,4-dioxo-3,4-dihidropirimidin-1-(2h)-il)¿4¿fluoro¿3¿hidroxi¿4¿metiltetrahidrofuran¿2¿il)metoxi) (fenoxi)fosforil)amino)propanoato de (s)- isopropil cristalino |
| EP2914250B1 (en) | 2012-11-05 | 2018-04-04 | Commissariat à l'Énergie Atomique et aux Énergies Alternatives | Combination of an anti-cancer agent such as a tyrosinekinase inhibitor and a stat5 antagonist, preferably a thiazolidinedione, for eliminating hematologic cancer stem cells in vivo and for preventing hematologic cancer relapse |
| US10034868B2 (en) | 2014-11-04 | 2018-07-31 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods for the prevention and the treatment of rapidly progressive glomerulonephritis |
| CN112423754A (zh) | 2018-03-05 | 2021-02-26 | 奥克梅斯制药爱尔兰有限公司 | 阿立哌唑的给药策略 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH619701A5 (es) | 1975-08-07 | 1980-10-15 | Bayer Ag | |
| JPS5522636A (en) | 1978-08-04 | 1980-02-18 | Takeda Chem Ind Ltd | Thiazoliding derivative |
| DE3010504A1 (de) | 1980-03-19 | 1981-10-01 | Basf Ag, 6700 Ludwigshafen | Verfahren zur herstellung von 2-hydroxyalkylchromanen |
| JPS58118577A (ja) * | 1982-01-07 | 1983-07-14 | Takeda Chem Ind Ltd | チアゾリジン誘導体 |
| JPS58201775A (ja) | 1982-05-17 | 1983-11-24 | Kuraray Co Ltd | ３，４−ジヒドロ−２ｈ−ベンゾピラン誘導体の製造方法 |
| PT79094B (en) * | 1983-08-29 | 1986-08-14 | Salk Inst For Biological Studi | Grf analogs |
| JPS6051189A (ja) | 1983-08-30 | 1985-03-22 | Sankyo Co Ltd | チアゾリジン誘導体およびその製造法 |
| JPS6136284A (ja) * | 1984-07-27 | 1986-02-20 | Sankyo Co Ltd | チアゾリジン誘導体およびその製造方法 |
-
1986
- 1986-02-25 DK DK198600878A patent/DK173350B1/da not_active IP Right Cessation
- 1986-02-26 DE DE8686301398T patent/DE3674089D1/de not_active Expired - Fee Related
- 1986-02-26 ES ES552502A patent/ES8802046A1/es not_active Expired
- 1986-02-26 AU AU54122/86A patent/AU588857B2/en not_active Ceased
- 1986-02-26 CA CA000502816A patent/CA1256106A/en not_active Expired
- 1986-02-26 EP EP86301398A patent/EP0207581B1/en not_active Expired - Lifetime
- 1986-02-26 IE IE51286A patent/IE58853B1/en not_active IP Right Cessation
- 1986-02-26 KR KR1019860001352A patent/KR930003335B1/ko not_active IP Right Cessation
- 1986-02-26 FI FI860832A patent/FI82693C/fi not_active IP Right Cessation
-
1990
- 1990-07-25 US US07/560,466 patent/US5104888A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| AU5412286A (en) | 1986-09-04 |
| AU588857B2 (en) | 1989-09-28 |
| FI82693B (fi) | 1990-12-31 |
| DE3674089D1 (de) | 1990-10-18 |
| FI82693C (fi) | 1991-04-10 |
| EP0207581A2 (en) | 1987-01-07 |
| DK87886D0 (da) | 1986-02-25 |
| IE58853B1 (en) | 1993-11-17 |
| DK173350B1 (da) | 2000-08-07 |
| ES8802046A1 (es) | 1988-03-16 |
| EP0207581A3 (en) | 1987-07-01 |
| FI860832A (fi) | 1986-08-27 |
| US5104888A (en) | 1992-04-14 |
| KR860006458A (ko) | 1986-09-11 |
| KR930003335B1 (ko) | 1993-04-26 |
| EP0207581B1 (en) | 1990-09-12 |
| DK87886A (da) | 1986-08-27 |
| FI860832A0 (fi) | 1986-02-26 |
| CA1256106A (en) | 1989-06-20 |
| IE860512L (en) | 1986-08-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES552502A0 (es) | Un procedimiento para la preparacion de nuevos derivados de tiazolidina. | |
| ES553044A0 (es) | Un procedimiento para la preparacion de nuevos derivados de fenoxialquilaminopirimidina. | |
| ES554405A0 (es) | Un procedimiento para la preparacion de derivados de aza-indol. | |
| ES544644A0 (es) | Un procedimiento para la preparacion de derivados de carboxamidoadenosina. | |
| ES548430A0 (es) | Un procedimiento para la preparacion de nuevos derivados de carbazolona | |
| ES556145A0 (es) | Un procedimiento para la preparacion de nuevos derivados de piperazina. | |
| ES552052A0 (es) | Un procedimiento para la preparacion de derivados de androstendiona 4-sustituida. | |
| ES546236A0 (es) | Un procedimiento para la preparacion de derivados de bencimidasol. | |
| ES552189A0 (es) | Un procedimiento para la preparacion de derivados de piridimilmidazolidiona. | |
| ES552297A0 (es) | Un procedimiento para la preparacion de nuevos derivados de disacaridos o trisacaridos. | |
| ES542013A0 (es) | Un procedimiento para la preparacion de nuevos derivados de cefalosporina. | |
| ES550504A0 (es) | Un procedimiento para la preparacion de derivados de podofilotoxina. | |
| ES548774A0 (es) | Un procedimiento para la preparacion de derivados de cefalosporina. | |
| ES549498A0 (es) | Un procedimiento para la preparacion de nuevos derivados de cefalosporina. | |
| ES550819A0 (es) | Un procedimiento para preparar nuevos derivados de cefem. | |
| ES554286A0 (es) | Un procedimiento para la preparacion de nuevos derivados glicopepticos | |
| ES547805A0 (es) | Un procedimiento para la preparacion de nuevos derivados de guanina. | |
| ES548033A0 (es) | Un procedimiento para la preparacion de nuevos derivados pe-nem | |
| ES557397A0 (es) | Un procedimiento para preparar derivados arilicos de diemanidas. | |
| ES544970A0 (es) | Un procedimiento para la preparacion de derivados de benzo- tiofeno | |
| ES557839A0 (es) | Un procedimiento para la preparacion de derivados de piperazinilo 1-4-disustituidos. | |
| ES551755A0 (es) | Un procedimiento para la preparacion de derivados de d4-y-d5-androsteno nuevos | |
| ES552241A0 (es) | Un procedimiento para la preparacion de nuevos derivados de pirazolopiridinas. | |
| ES548960A0 (es) | Un procedimiento para la preparacion de derivados de hidan- toina | |
| ES554469A0 (es) | Un procedimiento para la preparacion de derivados de mitomicina c |